200 related articles for article (PubMed ID: 25723098)
1. Involvement of the inhibition of intestinal glucuronidation in enhancing the oral bioavailability of resveratrol by labrasol containing nanoemulsions.
Zhou J; Zhou M; Yang FF; Liu CY; Pan RL; Chang Q; Liu XM; Liao YH
Mol Pharm; 2015 Apr; 12(4):1084-95. PubMed ID: 25723098
[TBL] [Abstract][Full Text] [Related]
2. Sodium Oleate-Based Nanoemulsion Enhances Oral Absorption of Chrysin through Inhibition of UGT-Mediated Metabolism.
Dong D; Quan E; Yuan X; Xie Q; Li Z; Wu B
Mol Pharm; 2017 Sep; 14(9):2864-2874. PubMed ID: 27983856
[TBL] [Abstract][Full Text] [Related]
3. Improving oral bioavailability of resveratrol by a UDP-glucuronosyltransferase inhibitory excipient-based self-microemulsion.
Yang FF; Zhou J; Hu X; Cong ZQ; Liu CY; Pan RL; Chang Q; Liu XM; Liao YH
Eur J Pharm Sci; 2018 Mar; 114():303-309. PubMed ID: 29292019
[TBL] [Abstract][Full Text] [Related]
4. Effects of Ganoderma, Rhodiola and grape seed extracts on the glucuronidation and oral bioavailability of resveratrol in rats.
Cong Z; Zhou M; Yang F; Liu C; Pan R; Chang Q; Liu X; Liao Y
Nat Prod Res; 2019 Mar; 33(5):767-771. PubMed ID: 29172735
[TBL] [Abstract][Full Text] [Related]
5. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
Ghassemi S; Haeri A; Shahhosseini S; Dadashzadeh S
AAPS PharmSciTech; 2018 Oct; 19(7):2961-2970. PubMed ID: 30030724
[TBL] [Abstract][Full Text] [Related]
6. Dual Strategy for Improving the Oral Bioavailability of Resveratrol: Enhancing Water Solubility and Inhibiting Glucuronidation.
Li Y; Zhang R; Zhang Q; Luo M; Lu F; He Z; Jiang Q; Zhang T
J Agric Food Chem; 2021 Aug; 69(32):9249-9258. PubMed ID: 34357767
[TBL] [Abstract][Full Text] [Related]
7. Elevated system exposures of baicalin after combinatory oral administration of rhein and baicalin: Mainly related to breast cancer resistance protein (ABCG2), not UDP-glucuronosyltransferases.
Zhang Y; Zhang M; Hu G; Zhang Z; Song R
J Ethnopharmacol; 2020 Mar; 250():112528. PubMed ID: 31884038
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability of encapsulated resveratrol into nanoemulsion-based delivery systems.
Sessa M; Balestrieri ML; Ferrari G; Servillo L; Castaldo D; D'Onofrio N; Donsì F; Tsao R
Food Chem; 2014 Mar; 147():42-50. PubMed ID: 24206683
[TBL] [Abstract][Full Text] [Related]
9. The Effect of Piperine Pro-Nano Lipospheres on Direct Intestinal Phase II Metabolism: The Raloxifene Paradigm of Enhanced Oral Bioavailability.
Izgelov D; Cherniakov I; Aldouby Bier G; Domb AJ; Hoffman A
Mol Pharm; 2018 Apr; 15(4):1548-1555. PubMed ID: 29537855
[TBL] [Abstract][Full Text] [Related]
10. Galactosylated PLGA nanoparticles for the oral delivery of resveratrol: enhanced bioavailability and in vitro anti-inflammatory activity.
Siu FY; Ye S; Lin H; Li S
Int J Nanomedicine; 2018; 13():4133-4144. PubMed ID: 30038494
[TBL] [Abstract][Full Text] [Related]
11. Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms.
Brill SS; Furimsky AM; Ho MN; Furniss MJ; Li Y; Green AG; Bradford WW; Green CE; Kapetanovic IM; Iyer LV
J Pharm Pharmacol; 2006 Apr; 58(4):469-79. PubMed ID: 16597364
[TBL] [Abstract][Full Text] [Related]
12. Regioselective glucuronidation of denopamine: marked species differences and identification of human udp-glucuronosyltransferase isoform.
Kaji H; Kume T
Drug Metab Dispos; 2005 Mar; 33(3):403-12. PubMed ID: 15608137
[TBL] [Abstract][Full Text] [Related]
13. Glucuronidation of curcuminoids by human microsomal and recombinant UDP-glucuronosyltransferases.
Hoehle SI; Pfeiffer E; Metzler M
Mol Nutr Food Res; 2007 Aug; 51(8):932-8. PubMed ID: 17628876
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of glucuronidation and oxidative metabolism of buprenorphine using GRAS compounds or dietary constituents/supplements: in vitro proof of concept.
Maharao NV; Joshi AA; Gerk PM
Biopharm Drug Dispos; 2017 Mar; 38(2):139-154. PubMed ID: 27925249
[TBL] [Abstract][Full Text] [Related]
15. Enhancing in vivo oral bioavailability of cajaninstilbene acid using UDP-glucuronosyl transferase inhibitory excipient containing self-microemulsion.
Yang FF; Ji CY; Cong ZQ; Ma SQ; Liu CY; Pan RL; Chang Q; Ji YB; Liao YH
Colloids Surf B Biointerfaces; 2020 Sep; 193():111069. PubMed ID: 32371286
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsion strategy for olmesartan medoxomil improves oral absorption and extended antihypertensive activity in hypertensive rats.
Gorain B; Choudhury H; Kundu A; Sarkar L; Karmakar S; Jaisankar P; Pal TK
Colloids Surf B Biointerfaces; 2014 Mar; 115():286-94. PubMed ID: 24388859
[TBL] [Abstract][Full Text] [Related]
17. Glucuronidation of haloperidol by rat liver microsomes: involvement of family 2 UDP-glucuronosyltransferases.
Narayanan R; LeDuc B; Williams DA
Life Sci; 2004 Apr; 74(20):2527-39. PubMed ID: 15010263
[TBL] [Abstract][Full Text] [Related]
18. Characterizing the effects of common UDP glucuronosyltransferase (UGT) 1A6 and UGT1A1 polymorphisms on cis- and trans-resveratrol glucuronidation.
Iwuchukwu OF; Ajetunmobi J; Ung D; Nagar S
Drug Metab Dispos; 2009 Aug; 37(8):1726-32. PubMed ID: 19406951
[TBL] [Abstract][Full Text] [Related]
19. Intestinal glucuronidation metabolism may have a greater impact on oral bioavailability than hepatic glucuronidation metabolism in humans: a study with raloxifene, substrate for UGT1A1, 1A8, 1A9, and 1A10.
Mizuma T
Int J Pharm; 2009 Aug; 378(1-2):140-1. PubMed ID: 19486934
[TBL] [Abstract][Full Text] [Related]
20. Cytochromes P450 Inhibitory Excipient-Based Self-Microemulsions for the Improved Bioavailability of Protopanaxatriol and Protopanaxadiol: Preparation and Evaluation.
Yang F; Zhou J; Liu C; Hu X; Pan R; Chang Q; Liu X; Liao Y
Planta Med; 2017 Mar; 83(5):453-460. PubMed ID: 27220080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
